EyePoint Pharmaceuticals Inc (NASDAQ:EYPT)
| 10.50 Delayed Data As of Aug 18 |  -0.10 / -0.94%Today’s Change | 7.00 Today|||52-Week Range 21.50 | -14.22% Year-to-Date |
Five Year Financial Summary
| All Currency in US Dollars | 4 Quarter Trend | |||||
|---|---|---|---|---|---|---|
| Quarter 1 2018 | Quarter 2 2018 | Quarter 1 2019 | Quarter 2 2019 | |||
| Assets | Cash | 16.3M | 38.8M | 43.4M | 44.2M | |
| Short Term Investment Cash | -552.0K | 22.4M | -1.9M | 782.0K | ||
| Cash & Short Term Investments | 16.3M | 38.8M | 43.4M | 44.2M | ||
| Receivables | Receivables | 478.0K | 353.0K | 2.3M | 9.6M | |
| Inventories | Inventories | 0.00 | -- | 886.0K | 1.7M | |
| Current Assets | Other Current Assets | 851.0K | 780.0K | 1.8M | 3.1M | |
| Current Assets | 17.7M | 39.9M | 48.4M | 58.6M | ||
| Total Assets | Property, Plant and Equipment - Gross | -- | 906.0K | -- | -- | |
| Depreciation | -- | -653.0K | -- | -- | ||
| Intangible Assets | 32.0M | 31.4M | 29.5M | 28.9M | ||
| Other Assets | 32.1M | 31.4M | 32.9M | 28.9M | ||
| Total Assets | 50.2M | 71.7M | 81.9M | 91.3M | ||
| Liabilities | Accounts Payable | 2.8M | 2.9M | 6.3M | 6.1M | |
| Short Term Debt | 0.00 | 0.00 | 0.00 | 441.0K | ||
| Accrued Expenses | 17.1M | 16.7M | 17.9M | 3.2M | ||
| Other Current Liabilities | 17.3M | 17.0M | 18.3M | 4.2M | ||
| Other Liabilities | 21.2M | 21.7M | 24.7M | 10.7M | ||
| Total Liabilities | Long Term Debt | 12.9M | 17.3M | 32.0M | 49.4M | |
| Other Liabilities | 7.9M | 21.0M | 5.4M | 3.0M | ||
| Total Liabilities | 42.0M | 60.0M | 62.0M | 63.1M | ||
| Equity | Minority Interest | 0.00 | 0.00 | 0.00 | 0.00 | -- |
| Preferred Stock | 0.00 | 0.00 | 0.00 | 0.00 | -- | |
| Common Equity | 8.2M | 11.7M | 19.9M | 28.2M | ||
| Total Shareholder Equity | 8.2M | 11.7M | 19.9M | 28.2M | ||
| Share Information | Common Shares Outstanding | 53.9M | 74.5M | 95.6M | 106.3M | |
| Addtl. Info. | No data currently available for this section. | |||||
